Enanta Pharmaceuticals reported $47.36M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Acorda Therapeutics ACOR:US USD 38.5M 6.47M
Amgen AMGN:US USD 3.91B 504M
Anika Therapeutics ANIK:US USD 28.58M 14.46M
Arrowhead Research ARWR:US USD 115.4M 10.08M
AstraZeneca AZN:LN USD 9.74B 495M
Biocryst Pharmaceuticals BCRX:US USD 93.27M 6.98M
Biogen BIIB:US USD 1.19B 1.45B
Bristol Myers Squibb BMY:US USD 8.75B 552M
Clovis Oncology CLVS:US USD 74.9M 16.63M
Enanta Pharmaceuticals ENTA:US USD 47.36M 4.65M
Gilead Sciences GILD:US USD 4.2B 26M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Insmed INSM:US USD 195.43M 41.89M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
IONIS PHARMACEUT IONS:US USD 218.92M 384K
Johnson & Johnson JNJ:US USD 17.97B 211M
Karyopharm Therapeutics KPTI:US USD 66.98M 15.6M
Ligand Pharmaceuticals LGND:US USD 65.45M 9.36M
Marinus Pharmaceuticals MRNS:US USD 32.44M 6.12M
Merk MRK:US USD 10.97B 1.31B
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Novartis NOVN:VX USD 10.67B 183M
Novavax NVAX:US USD 861.77M 192.88M
Pfizer PFE:US USD 13.23B 2.41B
Ptc Therapeutics PTCT:US USD 285.31M 27.43M
Sarepta Therapeutics SRPT:US USD 487.06M 42.45M
Vertex Pharmaceuticals VRTX:US USD 1.21B 117.7M
Vital Therapies VTL:US USD 20.12M 494K
YTE INCY:US USD 684.93M 27.96M